JP2013056949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013056949A5 JP2013056949A5 JP2012288298A JP2012288298A JP2013056949A5 JP 2013056949 A5 JP2013056949 A5 JP 2013056949A5 JP 2012288298 A JP2012288298 A JP 2012288298A JP 2012288298 A JP2012288298 A JP 2012288298A JP 2013056949 A5 JP2013056949 A5 JP 2013056949A5
- Authority
- JP
- Japan
- Prior art keywords
- antagonist
- administered
- pharmaceutical formulation
- pharmaceutical preparation
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002474 gonadorelin antagonist Substances 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 claims 4
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 claims 4
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 claims 4
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 claims 4
- 102000006771 Gonadotropins Human genes 0.000 claims 3
- 108010086677 Gonadotropins Proteins 0.000 claims 3
- 239000002622 gonadotropin Substances 0.000 claims 3
- 239000000556 agonist Substances 0.000 claims 2
- 230000003325 follicular Effects 0.000 claims 2
- 208000000509 infertility Diseases 0.000 claims 2
- 230000036512 infertility Effects 0.000 claims 2
- 231100000535 infertility Toxicity 0.000 claims 2
- 230000029849 luteinization Effects 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 229940011871 estrogen Drugs 0.000 claims 1
- 239000000262 estrogen Substances 0.000 claims 1
- 230000008217 follicular development Effects 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 230000002611 ovarian Effects 0.000 claims 1
- 230000016087 ovulation Effects 0.000 claims 1
- 230000027758 ovulation cycle Effects 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000009469 supplementation Effects 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1128296P | 1996-02-07 | 1996-02-07 | |
| US60/011282 | 1996-02-07 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009096656A Division JP2009155345A (ja) | 1996-02-07 | 2009-04-13 | 不妊症を治療するための製薬学的製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013056949A JP2013056949A (ja) | 2013-03-28 |
| JP2013056949A5 true JP2013056949A5 (enExample) | 2013-05-09 |
Family
ID=21749681
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9022359A Pending JPH09227404A (ja) | 1996-02-07 | 1997-02-05 | 不妊症を治療するための製薬学的製剤 |
| JP2009096656A Pending JP2009155345A (ja) | 1996-02-07 | 2009-04-13 | 不妊症を治療するための製薬学的製剤 |
| JP2012288298A Pending JP2013056949A (ja) | 1996-02-07 | 2012-12-28 | 不妊症を治療するための製薬学的製剤 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9022359A Pending JPH09227404A (ja) | 1996-02-07 | 1997-02-05 | 不妊症を治療するための製薬学的製剤 |
| JP2009096656A Pending JP2009155345A (ja) | 1996-02-07 | 2009-04-13 | 不妊症を治療するための製薬学的製剤 |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US7393834B2 (enExample) |
| EP (1) | EP0788799A3 (enExample) |
| JP (3) | JPH09227404A (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
| EP0788799A3 (en) | 1996-02-07 | 1998-10-21 | ASTA Medica Aktiengesellschaft | LHRH-Antagonists in the treatment of fertility disorders |
| EP1082129B1 (en) | 1998-04-23 | 2003-10-29 | Zentaris AG | Method for the treatment of fertility disorders |
| US8173592B1 (en) | 1999-03-31 | 2012-05-08 | Zentaris Ivf Gmbh | Method for a programmed controlled ovarian stimulation protocol |
| US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
| US20030186892A1 (en) * | 2002-03-28 | 2003-10-02 | Rajneesh Taneja | Enhancement of endogenous gonadotropin production |
| PL373991A1 (en) * | 2002-06-07 | 2005-09-19 | Ares Trading S.A. | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| PT2621517E (pt) | 2010-09-29 | 2015-10-16 | Ferring Bv | Composição para uso no tratamento da infertilidade |
| US20240123021A1 (en) | 2021-06-25 | 2024-04-18 | Extrovis Ag | Pharmaceutical compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4342091A1 (de) | 1993-12-09 | 1995-06-14 | Asta Medica Ag | Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten |
| EP0788799A3 (en) | 1996-02-07 | 1998-10-21 | ASTA Medica Aktiengesellschaft | LHRH-Antagonists in the treatment of fertility disorders |
| US5945128A (en) | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
| DE19712718C2 (de) | 1997-03-26 | 1999-09-23 | Asta Medica Ag | Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung |
| EP1082129B1 (en) * | 1998-04-23 | 2003-10-29 | Zentaris AG | Method for the treatment of fertility disorders |
| US8173592B1 (en) * | 1999-03-31 | 2012-05-08 | Zentaris Ivf Gmbh | Method for a programmed controlled ovarian stimulation protocol |
-
1997
- 1997-01-21 EP EP97100852A patent/EP0788799A3/en not_active Withdrawn
- 1997-02-05 JP JP9022359A patent/JPH09227404A/ja active Pending
-
2003
- 2003-09-15 US US10/661,780 patent/US7393834B2/en not_active Expired - Fee Related
-
2009
- 2009-04-13 JP JP2009096656A patent/JP2009155345A/ja active Pending
-
2010
- 2010-11-08 US US12/941,629 patent/US9107871B2/en not_active Expired - Fee Related
-
2012
- 2012-12-28 JP JP2012288298A patent/JP2013056949A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013056949A5 (enExample) | ||
| IL319463A (en) | A preparation containing a biological substance that activates innate immunity for use in cancer treatment | |
| JP2018111728A5 (enExample) | ||
| WO2017042607A3 (en) | Compositions comprising meloxicam-cyclodextrin inclusion complexes and methods of treating acute pain | |
| HRP20170358T1 (hr) | Inhibitori histonskih demetilaza | |
| PH12017502416A1 (en) | 17-hydroxyprogesterone ester-containing oral compositions and related methods | |
| MX2023010063A (es) | Un esteroide c21-n-pirazolilo 19-nor c3,3-disustituido, y metodos de uso del mismo. | |
| JP2017533972A5 (enExample) | ||
| PH12022550753A1 (en) | A mesenchymal stem cell storing or transport formulation and methods of making and using the same | |
| RU2012134065A (ru) | Альфа-2 адренергический агонист, обладающий эффектом длительного снижения внутриглазного давления | |
| PH12017502252B1 (en) | Stable pharmaceutical composition for oral administration | |
| MX359672B (es) | Metodo para manejo de dolor cronico y tratamiento usando hcg. | |
| JP2017519762A5 (enExample) | ||
| MX2015010594A (es) | Esteres de testosterona de cadena larga lipobalanceados para suministro oral. | |
| EA201500694A1 (ru) | Монолитная лекарственная форма для модифицированного высвобождения комбинации активных ингредиентов | |
| JP2015506988A5 (enExample) | ||
| JP2017530142A5 (enExample) | ||
| WO2016077565A3 (en) | Methods for chronic pain management and treatment using hcg | |
| RU2020121929A (ru) | Фармацевтические комбинации | |
| RU2013126798A (ru) | Комбинированная терапия дексаметазоном | |
| CN205005991U (zh) | 一种红豆杉保健围巾 | |
| PH12019501607A1 (en) | Tapentadol nasal composition | |
| PL404379A1 (pl) | Maść | |
| Nayot | Headache: 3 case reports | |
| EA202191570A1 (ru) | Композиции для доставки терапевтических средств, способы их применения и получения |